Did You See Our First Big Win?

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email.

Saturday, March 2, 2018 This Is How You Identify the Top-Tier Cannabis Stocks By Greg Miller Earlier this week, I sent a trade alert to the members of Cannabis Investor's Report. After opening a position on December 17, 2018, I decided it was time to sell Hexo Corp. (NYSEMKT: HEXO). If you were able to follow along my instructions exactly, you made a 40% profit. If you aren't familiar with the company, Hexo produces marijuana for the medical market in Canada, and it's gearing up for the recreational market. As a small (by Canadian standards) producer with a regional focus, HEXO could prove an attractive acquisition candidate at some point. Cannabis Profits Daily readers won't be surprised to learn that I like Hexo's branding strategy - that's the key differentiator I see separating the good companies from the also-rans. Hexo also scored with a lot of the other things I like to see in a cannabis company - low cost production, a top-notch management team, and a key partnership with a larger company (in this case Molson Coors). An imminent listing on the NYSE American exchange didn't hurt either. I still like the company, but I thought it was as good of a time as ever to net a double-digit gain in a short time. My trader hat was on for this trade as much as my analyst hat. Hexo had been unfairly beaten up during the cannabis market downturn in November and December of last year. I knew two things: that it was time for the cannabis market to turn, and that Hexo would be among the strongest and fastest turnarounds. This chart tells the story. December 17 was the date I identified when it was time for the market to turn, so I definitely wanted to put Cannabis Investor's Report members in something. But what? Checking the charts, I found that after being a better performer for some time, albeit in a falling market, Hexo's performance fell short of industry leader Aurora Cannabis (NYSE: ACB)'s right on the date when I called the turn. That was our chance! We got one of the highest-quality cannabis stocks not only at a low price, but at a low price relative to its closest comparable stock. You can see the results after that. Aurora's stock recovered nicely - it was up 33.6% in the 2.5 months since we entered the trade. But Hexo recovered even more nicely - up 54%. And that disparity in return is why I recommended selling it when I did. It bounced back stronger than Aurora and much stronger than the overall stock market. With it now trading closer to a fair price, I judged that it was appropriate to take some money off the table to make room for the next opportunity. Why not buy Aurora, since it's now the relative underperformer? Because I think there are even better opportunities now among some smaller players. Back in those down days of December I knew that the biggest, most liquid cannabis stocks would be the first to come back. But having come back, they're now more driven by their actual results than by technical factors. I'm excited to hear how you're going to use the money you made from the Hexo trade in your personal lives. I know some of you are using it to buy more cannabis stocks, and we've seen others say they want to sit on the gains and wait for the next big opportunity. Whatever you decide, we're thrilled to be there with you for the ride. Thanks for being an important part of the National Institute for Cannabis Investors, Greg Miller Executive Director, National Institute for Cannabis Investors P.S. This is the ultimate pot stock investing tool - and it contains information on hundreds of the biggest, most tradeable cannabis stocks. Our highly secured platform has real data on the industry's best up-and-coming cannabis companies, so you can locate tomorrow's winners on your own - and for LIFE. Click here to see the details. Uncover the IPO Strategy That One Man Used to Create $2.2 Billion in Less Than Two Years! Danny is famous for being the "behind-the-scenes" architect for two of the biggest IPOs in cannabis history. The two cannabis firms he's helped take public have created $2.2 billion in new wealth for shareholders. Fact is, he has the power to open doors in the cannabis industry that only a few can. That's why we wanted to sit down with Danny and extract his wisdom regarding the current market climate for cannabis IPOs. We got him to talk about where the "big money" can be made, the ripple effects of full U.S. legalization, and more. He's even going to reveal four cannabis IPO recommendations he's got locked and loaded for you right now. All you have to do is click here to get all of Danny's insights, including where he believes investors should put their money right now. One catalyst could spark the biggest play in cannabis history Since it entered the spotlight, legal cannabis has been breaking barriers and shattering expectations... but most importantly, it could be opening up the profit opportunity of a lifetime. But this is just the start... because once a single hurdle is cleared, you could see your initial stake multiply 10-fold. Here's the full story. Critical: It's time to act on what could be the biggest IPO in marijuana history Recently, our team of pot stock analysts sent out an alert for a small company that just completed their long-awaited IPO. But if you missed the boat on this the first time around, you have a rare second chance to lock in a ground-floor opportunity in one of tomorrow's biggest household names. This could easily become the next 1,000% winner - so I recommend you move fast. Click here to learn more. You are receiving this e-mail at its028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions